{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T05:33:29Z","timestamp":1789882409147,"version":"4.0.1"},"reference-count":48,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2014,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">Mycoplasma genitalium<\/jats:named-content>\n            has become well established as an etiological agent of sexually transmitted infections, but due to its fastidious growth requirements, only a few\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">M. genitalium<\/jats:named-content>\n            strains are available to determine the MICs of currently used and new antimicrobial agents. Recent clinical trials have suggested that treatment with azithromycin has decreasing efficacy due to an increasing prevalence of macrolide resistance, and alternative treatment with moxifloxacin is similarly under pressure from emerging resistance. Thus, there is an urgent need for new antimicrobials. The\n            <jats:italic>in vitro<\/jats:italic>\n            activity of the newly developed fluoroketolide solithromycin (CEM-101) was evaluated against a collection of 40\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">M. genitalium<\/jats:named-content>\n            strains, including 15 with high-level macrolide resistance and 5 multidrug-resistant strains with resistance to both macrolides and quinolones. Furthermore, the MIC of solithromycin was correlated with mutations in the 23S rRNA gene and in the genes encoding ribosomal proteins L4 and L22. The\n            <jats:italic>in vitro<\/jats:italic>\n            results showed that solithromycin has activity against\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">M. genitalium<\/jats:named-content>\n            superior to that of other macrolides, doxycycline, and fluoroquinolones. Accordingly, this new fluoroketolide might be an effective option for treatment of\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">M. genitalium<\/jats:named-content>\n            infections. However, the efficacy of solithromycin in clinical trials with follow-up for test of cure and detection of genotypic and phenotypic resistance needs to be evaluated prior to widespread use. In a phase 2 clinical trial, solithromycin was highly effective as a single oral dose against\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">C. trachomatis<\/jats:named-content>\n            and\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">Neisseria gonorrhoeae<\/jats:named-content>\n            , suggesting that solithromycin could be a treatment option for several sexually transmitted infections, including in syndromic treatment of urethral and vaginal discharge.\n          <\/jats:p>","DOI":"10.1128\/aac.02411-14","type":"journal-article","created":{"date-parts":[[2014,3,18]],"date-time":"2014-03-18T00:49:54Z","timestamp":1395103794000},"page":"3151-3156","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":67,"title":["<i>In Vitro<\/i>\n            Activity of the New Fluoroketolide Solithromycin (CEM-101) against Macrolide-Resistant and -Susceptible Mycoplasma genitalium Strains"],"prefix":"10.1128","volume":"58","author":[{"given":"J\u00f8rgen Skov","family":"Jensen","sequence":"first","affiliation":[{"name":"Microbiology and Infection Control, Sexually Transmitted Bacterial Infections, Research and Development, Statens Serum Institut, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhavathi","family":"Fernandes","sequence":"additional","affiliation":[{"name":"Cempra, Inc., Chapel Hill, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Unemo","sequence":"additional","affiliation":[{"name":"WHO Collaborating Centre for Gonorrhoea and other STIs, Department of Laboratory Medicine, Microbiology, \u00d6rebro University Hospital, \u00d6rebro, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(81)92461-2"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00006-11"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07848-0"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1086\/367992"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2005.015701"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2004.012062"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2004.010439"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2006.022970"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1086\/656739"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2005.074062"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003618"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2005.018598"},{"key":"e_1_3_2_14_2","first-page":"119","article-title":"The biology of Mycoplasma genitalium","volume":"13","author":"Taylor-Robinson D","year":"2000","unstructured":"Taylor-RobinsonDGilroyCBJensenJS. 2000. The biology of Mycoplasma genitalium. Venereology 13:119\u2013127.","journal-title":"Venereology"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00724-09"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00090-09"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/sti.79.4.318"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2007.027375"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1086\/599034"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq074"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis1022"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1258\/ijsa.2008.008038"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1086\/593188"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061481"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/0956462413502008"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1099\/00207713-33-2-387"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.37.10.3300-3307.1999"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00003-06"},{"key":"e_1_3_2_29_2","first-page":"1","article-title":"Mycoplasma genitalium infections. Diagnosis, clinical aspects, and pathogenesis","volume":"53","author":"Jensen JS","year":"2006","unstructured":"JensenJS. 2006. Mycoplasma genitalium infections. Diagnosis, clinical aspects, and pathogenesis. Dan. Med. Bull. 53:1\u201327.","journal-title":"Dan. Med. Bull."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.2.683-692.2004"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.12.4993-4998.2005"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.1.281-288.2005"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-8-130"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015660"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.3402\/ijch.v71i0.18203"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00203-09"},{"key":"e_1_3_2_37_2","first-page":"91","article-title":"Intracellular location of Mycoplasma genitalium in cultured Vero cells as demonstrated by electron microscopy","volume":"75","author":"Jensen JS","year":"1994","unstructured":"JensenJSBlomJLindK. 1994. Intracellular location of Mycoplasma genitalium in cultured Vero cells as demonstrated by electron microscopy. Int. J. Exp. Pathol. 75:91\u201398.","journal-title":"Int. J. Exp. Pathol."},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01429-10"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00197-13"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01123-09"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00860-10"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.2.460-465.2004"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks174"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01343-09"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00036-12"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2013-051184.0092"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.34.2.286-291.1996"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02056-06"},{"key":"e_1_3_2_49_2","author":"Salado-Rasmussen K","unstructured":"Salado-RasmussenKJensenJS. Clin. Infect. Dis., in press.","journal-title":"Clin. Infect. Dis."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02411-14","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02411-14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T22:41:51Z","timestamp":1645483311000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.02411-14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["10.1128\/AAC.02411-14"],"URL":"https:\/\/doi.org\/10.1128\/aac.02411-14","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"2014-01-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-03-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-05-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}